Delivery Order SPE2DB24D3014-SPE2DB25FKRUH

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.64 firm fixed price delivery order is for the supply of 4,564,702,627 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of 4,565,923,013 units of Tamsulosin HCl 0.4 mg capsules. The award, valued at $3,760.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen for pharmaceutical and medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. Amerisourcebergen, a large pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,102,829 units of Tamsulosin HCl 0.4 mg capsules. The contract, a Firm Fixed Price Delivery Order, has a completion date of October 16, 2024 and a ceiling value of $16,332.76. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,097,622 units of Tamsulosin HCl 0.4 mg capsules. The contract has a firm fixed price of $1,881.97 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.04 firm fixed-price delivery order contract is for the supply of 4,566,690,189 units of the prescription medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a Delivery Order worth $3,583.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of 4,563,755,368 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of February 26, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a Defense agency, on July 11, 2024. The $12,855.94 Firm Fixed Price Delivery Order is for the supply of 4,565,121,081 units of 0.4 mg Tamsulosin HCl capsules. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $65,411.87 to provide 4,564,298,844 capsules of Tamsulosin HCL 0.4 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,697.77 to provide 1,000 units of the generic pharmaceutical drug Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31,...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKRUH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,086,886 units of the prescription drug Tamsulosin HCl 0.4 mg capsules. The $3,502.99 fixed-price delivery order has an ultimate completion date of October 15, 2024. Amerisourcebergen, a leading pharmaceutical distributor, has been awarded this contract under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which is valued up to $999,999,999 through December 2025 and enables the DLA to efficiently procure a range of medical commodities to support military healthcare programs. This contract award does not utilize any set-aside designations.

Generated 1/10/25, 9:02 AM